About
Based in
Investor Contact:
Managing Director
jfeffer@lifesciadvisors.com
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.85 USD | +2.09% | +5.38% | -33.56% |
05-13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
05-08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
About
Based in
Investor Contact:
Managing Director
jfeffer@lifesciadvisors.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-33.56% | 193M | |
+5.16% | 212B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-4.27% | 39.3B | |
+0.88% | 35.97B | |
+8.44% | 27B |